Kinled is a company which retains the assets of the Anglo-Austrian Aisher Family through direct investments in innovative businesses in the Life Science and Digital Technology sectors.
Investment Type: Venture Capital
Mentions in press and media 7
| Date | Title | Description | Source |
| 28.02.2024 | CEBINA announces the launch of DanubeNeuro, an acceleration ... | VIENNA, AUSTRIA, February 28, 2024 /EINPresswire.com/ -- CEBINA GmbH, Central European Biotech Incub... | einpresswi... |
| 13.02.2023 | Swiss-based Nanoflex Robotics bags €11.2M for its robotic en... | Zurich-based Nanoflex Robotics, a company that provides advanced medical robotic interventions for t... | siliconcan... |
| 10.02.2023 | ETH medtech spinoff secures USD 12 million | startuptic... | |
| 04.10.2022 | CHF1.3 million to bring precision medicine to all cancer pat... | startuptic... | |
| 26.10.2016 | Iproteos cierra una ronda de €1,5M liderada por CaixaCR, acu... | 26/10/2016 IPROTEOS CIERRA UNA RONDA DE €1,5 MILLONES LIDERADA POR CAIXA CAPITAL RISC, ACUDEN KINLE... | webcapital... |
| 25.10.2016 | KB Medical SA Raises CHF 2.5 Million in Series B | startuptic... | |
| 27.05.2016 | Aleva Neurotherapeutics Raises USD 18 Million in Series C Fi... | startuptic... |